Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of the Neuropsychological Evaluation for Early Diagnosis of Progressive Supranuclear Palsy

NCT03478124 is registered in ClinicalTrials.gov with Ospedale Generale Di Zona Moriggia-Pelascini as lead sponsor.

NCT NCT03478124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03478124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of the Neuropsychological Evaluation for Early Diagnosis of Progressive Supranuclear Palsy
Lead sponsor
Ospedale Generale Di Zona Moriggia-Pelascini
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
March 2, 2018
Enrollment
112 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, progressive supranuclear palsy